Sedana Medical AB (FRA:7D2A)
€ 1.066 0.054 (5.34%) Market Cap: 110.49 Mil Enterprise Value: 91.51 Mil PE Ratio: 0 PB Ratio: 1.15 GF Score: 65/100

Q4 2023 Sedana Medical AB (publ) Earnings Call Transcript

Feb 15, 2024 / 12:30PM GMT
Release Date Price: €1.51 (-10.00%)
Operator

Hello, and welcome to today's webcast with Sedana Medical with CEO, Johannes Doll; CFO, Johan Spetz; and CMO, Peter Sackey, who will present the year-end report for 2023. (Operator Instructions) And with that said, I leave the floor to you, Johannes.

Johannes Doll
Sedana Medical AB - President &CEO

Very welcome to Sedana Medical's Q4 and full-year report 2023. With me, I have the usual crew consisting of our Chief Medical Officer, Peter Sackey, who will later on talk about our clinical activities and our CFO, Johan Spetz, who will give you a detailed summary of the financials.

So if we start on page 3, please. Let's start with where we are as a company. We have three priorities, and these three priorities have not changed since two years ago, when we found ourselves in the post COVID hangover period. And they will stay the same for the time to come.

First, to bring Sedana back to a steady growth path in our existing business, second, to reach breakeven in our ex-US business as the first important step towards our longer-term

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot